Is It Time to Split Strategies to Treat Homologous Recombinant Deficiency in Pancreas Cancer?

Journal of Gastrointestinal Oncology - Hong Kong
doi 10.21037/jgo.2016.05.04
Full Text
Abstract

Available in full text

Date
Authors
Publisher

AME Publishing Company

Related search

Cancer Epigenetics: It Is Time to Move Forward to Therapy

Journal of Bioanalysis & Biomedicine
2012English

Is It Possible to Treat Vascular Dementia?

Frontiers of Neurology and Neuroscience
MedicineNeuroscienceNeurology
2009English

It Is the Time to Think About a Treat-To-Target Strategy for Knee Osteoarthritis

Therapeutics and Clinical Risk Management
2019English

Is It Possible to Treat Diseases by Metals?

Yakugaku Zasshi
PharmacologyPharmaceutical Science
2008English

Old Cavity, New Cancer – Is It Time to Re-Think?

JRSM Short Reports
2011English

It Is Time to Reduce the Mortality Rate of Oral Cancer in Chile.

Journal of Oral Research
2018English

How Safe It Is to Treat Pregnant FMF Patients With Anakinra?

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2015English

Coronary Angiography: Is It Time to Reassess?

Circulation
Cardiovascular MedicinePhysiologyCardiology
2013English

Cancer in Older Adults: To Treat or Not to Treat?

2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy